Posted on 04/17/2020 9:23:03 AM PDT by SeekAndFind
The Russian government has authorised the use of an anti-malarial drug to treat coronavirus patients despite international concerns over its safety and effectiveness.
The government published an order late Thursday allowing the use of hydroxychloroquine on patients after China donated more than 68,000 packs of the tablets to Russia.
The order was published after President Vladimir Putin had a phone conversation with Chinese leader Xi Jinping on Thursday evening.
It said the drug would be distributed to hospitals that are caring for patients who have tested positive for coronavirus or are suspected of having it. It said the drug’s safety and effectiveness will be monitored by the state health watchdog.
Hydroxychloroquine has been used for decades against malaria and is being tested worldwide against the virus along with another anti-malarial drug, chloroquine.
Both have potentially serious side effects, especially in high doses or when administered with other medications, and their use to treat the virus is still experimental, without having gone through exhaustive clinical testing.
Some see them as a potential weapon in the fight against the virus while there is still no proven cure or vaccine. Hydroxychloroquine has shown early promise against COVID-19 in small-scale studies in France and China to reduce virus levels among people badly infected.
US President Donald Trump has touted it as a coronavirus treatment and in the US a limited emergency-use authorisation has been granted to the drug.
But many scientists are urging caution until larger trials show whether it is safe and effective.
The European Medicines Agency has said that both chloroquine and hydroxychloroquine need to go through clinical trials and should not be used to treat virus cases unless there is a “national emergency.”
That can’t possibly be true.
Don’t they need to test to verify it first?
Everybody knows the Trump treatment is fake...
(And note that the same media that condemns the use of hydroxychloroquine as untested and a sham are blindly touting Gileads drug as a proven cure... when A - it’s not - it’s similar to the Z pak B - it hasn’t been proven and C - Gilead has said the studies aren’t yet conclusive.)
India, Russia, Israel still anecdotal until most countries use it I guess.
Some countries still have everyone rowing in the same direction.
Jokes on them! It doesn’t even work!!!
Oh wait...
More proof of Russian collusion with our POTUS!/s
This media report must have been written by fauci.
It may save people’s lives but it’s not a cure, so don’t use it.
“cure” seems to be a catch phrase.
How are the HIV meds approved when they are not “cures”.
Hmmmm....Hydroxychloroquine or Remdesivir? Which would I rather take?
The one still in trials that’s probably been tested for safety on a few thousand people, or the one that’s been used by literally millions over several decades. Not a tough choice, really.
Give me the HCQ drug combo first and if I regress, then the remdesivir. Hopefully, at least one of them does the trick.
RE: Give me the HCQ drug combo first and if I regress, then the remdesivir.
Yes, the HCQ Combo within the first 3 days of symptoms plus Covid-19 positive test. That almost always guarantees you get better within 5 to 6 days and won’t need Remdesivir later.
RE: It may save people’s lives but it’s not a cure, so don’t use it.
How do you define cure as it relates to Covid-19?
Good two part plan. Presently I'd be tempted by a three part plan: HCQ combo at first symptoms and diagnosis. If inadequate then add one dose of Ivermectin (safe, cheap and although little studied—for this—alleged to be fast.) If still not responding then the Remdesivir. Latter is IV so probably would in hospital. First two could be outpatient and hopefully would prevent most hospitalizations.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.